BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 30996051)

  • 1. Noncoding RNAs Serve as Diagnosis and Prognosis Biomarkers for Hepatocellular Carcinoma.
    Tan C; Cao J; Chen L; Xi X; Wang S; Zhu Y; Yang L; Ma L; Wang D; Yin J; Zhang T; John Lu Z
    Clin Chem; 2019 Jul; 65(7):905-915. PubMed ID: 30996051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating exosomal noncoding RNAs as prognostic biomarkers in human hepatocellular carcinoma.
    Lee YR; Kim G; Tak WY; Jang SY; Kweon YO; Park JG; Lee HW; Han YS; Chun JM; Park SY; Hur K
    Int J Cancer; 2019 Mar; 144(6):1444-1452. PubMed ID: 30338850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA sequencing of plasma exosomes revealed novel functional long noncoding RNAs in hepatocellular carcinoma.
    Huang X; Sun L; Wen S; Deng D; Wan F; He X; Tian L; Liang L; Wei C; Gao K; Fu Q; Li Y; Jiang J; Zhai R; He M
    Cancer Sci; 2020 Sep; 111(9):3338-3349. PubMed ID: 32506598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic utility of plasma lncRNA small nucleolar RNA host gene 1 in patients with hepatocellular carcinoma.
    Gao S; Xu X; Wang Y; Zhang W; Wang X
    Mol Med Rep; 2018 Sep; 18(3):3305-3313. PubMed ID: 30066898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of exosomal microRNA-224 in development of hepatocellular carcinoma and its diagnostic and prognostic value.
    Cui Y; Xu HF; Liu MY; Xu YJ; He JC; Zhou Y; Cang SD
    World J Gastroenterol; 2019 Apr; 25(15):1890-1898. PubMed ID: 31057302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of serum exosomal microRNAs as diagnostic and prognostic biomarkers for hepatocellular carcinoma.
    Xue X; Zhao Y; Wang X; Qin L; Hu R
    J Cell Biochem; 2019 Jan; 120(1):135-142. PubMed ID: 30238497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.
    Hou W; Bonkovsky HL
    World J Gastroenterol; 2013 Nov; 19(44):7836-45. PubMed ID: 24307777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of long non-coding RNA
    Luo P; Liang C; Zhang X; Liu X; Wang Y; Wu M; Feng X; Tu J
    Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29559565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating Noncoding RNAs Have a Promising Future Acting as Novel Biomarkers for Colorectal Cancer.
    Wang JJ; Wang X; Song YX; Zhao JH; Sun JX; Shi JX; Wu ZH; Wang ZN
    Dis Markers; 2019; 2019():2587109. PubMed ID: 31275444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of long non-coding RNA GAS5-AS1 and its prognostic and diagnostic significance in hepatocellular carcinoma.
    Wang Y; Jing W; Ma W; Liang C; Chai H; Tu J
    Cancer Biomark; 2018; 22(2):227-236. PubMed ID: 29660898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of exosomal noncoding RNA in hepatocellular carcinoma: a meta-analysis.
    Nie G; Lian N; Peng D; Lu J; Li B
    Carcinogenesis; 2022 Sep; 43(8):754-765. PubMed ID: 35904534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Exosomal Long Noncoding RNAs
    Xu H; Chen Y; Dong X; Wang X
    Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):710-716. PubMed ID: 29650788
    [No Abstract]   [Full Text] [Related]  

  • 13. The Circular RNA hsa_circ_0001445 Regulates the Proliferation and Migration of Hepatocellular Carcinoma and May Serve as a Diagnostic Biomarker.
    Zhang X; Zhou H; Jing W; Luo P; Qiu S; Liu X; Zhu M; Liang C; Yu M; Tu J
    Dis Markers; 2018; 2018():3073467. PubMed ID: 29785229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA Hsa_Circ_0091579 Serves as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma.
    Zhang C; Zhang C; Lin J; Wang H
    Cell Physiol Biochem; 2018; 51(1):290-300. PubMed ID: 30453307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospects of Noncoding RNAs in Hepatocellular Carcinoma.
    Zhou H; Xu Q; Ni C; Ye S; Xu X; Hu X; Jiang J; Hong Y; Huang D; Yang L
    Biomed Res Int; 2018; 2018():6579436. PubMed ID: 30148169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-free methylation markers with diagnostic and prognostic potential in hepatocellular carcinoma.
    Lu CY; Chen SY; Peng HL; Kan PY; Chang WC; Yen CJ
    Oncotarget; 2017 Jan; 8(4):6406-6418. PubMed ID: 28031532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noncoding RNA as therapeutic targets for hepatocellular carcinoma.
    George J; Patel T
    Semin Liver Dis; 2015 Feb; 35(1):63-74. PubMed ID: 25632936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum exosomal long noncoding RNA CRNDE as a prognostic biomarker for hepatocellular carcinoma.
    Wang T; Zhu H; Xiao M; Zhou S
    J Clin Lab Anal; 2021 Nov; 35(11):e23959. PubMed ID: 34612554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer.
    Liu T; Zhang X; Gao S; Jing F; Yang Y; Du L; Zheng G; Li P; Li C; Wang C
    Oncotarget; 2016 Dec; 7(51):85551-85563. PubMed ID: 27888803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating microRNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinoma.
    Qi J; Wang J; Katayama H; Sen S; Liu SM
    Neoplasma; 2013; 60(2):135-42. PubMed ID: 23259781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.